- Home
- TAOP vs COCP Comparison
TAOP vs COCP Comparison
Compare TAOP & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAOP | COCP |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 15.3M |
| IPO Year | 2012 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TAOP | COCP |
|---|---|---|
| Price | $1.30 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 6.8K | ★ 33.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,712,091.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.86 |
| 52 Week High | $8.78 | $2.19 |
Technical Indicators
Market Signals| Indicator | TAOP | COCP |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 50.02 |
| Support Level | $1.21 | $1.01 |
| Resistance Level | $1.59 | $1.11 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 19.44 | 44.50 |
Price Performance
Historical ComparisonAbout TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).